| Washington’s next health care debate will have more people with clinical and scientific credentials in the room. Thanks to the midterm elections, a record number of Democratic doctors, nurses, scientists and engineers will join Congress next year, my WaPo colleagues Rachel Roubein, Lena H. Sun and Caitlin Gilbert report. This includes the first Democratic practicing physician serving in the Senate in nearly 90 years. As part of the Democrats’ overwhelming majorities in the House and Senate, these new policymakers will be able to help chart the party’s health policy priorities — and some are likely to play a role in the oversight of Health Secretary Robert F. Kennedy Jr.’s tenure directing the nation’s health agenda. Here’s a breakdown of key names to know: SENATE - Pediatrician Annie Andrews is the first Democrat elected to the Senate in South Carolina in nearly 30 years. In August, she spoke at a conference about impeaching Kennedy. Even before launching her campaign, Andrews was critical on social media of Republicans’ health care policies.
- Senator-elect Abdul El-Sayed of Michigan is a former public health official with a medical degree, and who also wrote a book on Medicare-for-all. He beat former Republican congressman Mike Rogers in a race that had been rated as a toss-up, and one of the most expensive Senate races of the cycle.
During a Thursday appearance on CNN, El-Sayed said he wanted to investigate Kennedy’s role in agency staffing cuts and the impact it’s had on food safety. (This summer’s cyclosporiasis outbreak that sickened thousands had an outsize impact in Michigan.) El-Sayed also said the “bar is going to be extremely high” for approving any of Trump’s health nominees. HOUSE - Emergency room nurse Mitchell Berman flipped a House seat in a Wisconsin district President Donald Trump carried by 4.5 points in 2024.
- Pediatrician Richard Pan, who pushed back on nonmedical exemptions for childhood vaccine requirements as a state lawmaker, prevailed in a newly redrawn district in California. He told The Post that the idea of grilling Kennedy under oath was one of his motivators to run for Congress. But he said that, when he enters Congress next year, he will emphasize issues such as access to health care, “prioritizing the main concerns of the people.”
- Kristina Knickerbocker, a former Air Force nurse who most recently worked as a neuro-oncology nurse practitioner at Ohio State University, beat Rep. Mike Turner, a Republican who was first elected in 2002.
- Christina Bohannan, who has an engineering and law background, also flipped Iowa’s 1st Congressional District by defeating Republican Mariannette Miller-Meeks, a physician.
- In New Jersey’s 12th Congressional District, surgeon Adam Hamawy will fill the seat left vacant by fellow Democrat Bonnie Watson Coleman, who is retiring.
The wave is part of an effort by the organization 314 Action, which helps elect Democrats with a science background to public office. These lawmakers-elect argue that they have seen the health care system from the inside, and the impact that health policy developed in Washington has on their communities. It’s experience that some of them argue could bring a more practical perspective to policy debates — helping keep the focus on patients, affordability and access to care. Read the full story: “A ‘STEM wave’: Democratic doctors, scientists win record number of seats in midterms.” The Trump administration released updated payment rates for a wide swath of health care providers including physicians and hospitals. The rules issued by the Centers for Medicare and Medicaid Services are dense, technical and packed with seemingly minor changes to billing codes, quality measures, and payment formulas. But the stakes are anything but minor — and some providers are already expressing concerns. → Together, the physician fee schedule and hospital Outpatient Prospective Payment System (OPPS) rules help determine how billions of Medicare dollars flow through the health care system. They can affect provider revenue, what services get paid for, how care is delivered and, ultimately, what Americans with Medicare coverage can access. The two rules are a total of more than 3,600 pages of regulation. Let’s get into some key points of the physician and hospital outpatient rules. I’ll outline the smaller (447-page) home health rule tomorrow. Physician payment rules Medicare will pay most physicians less for their services next year, with a roughly 2.31 percent reduction in the baseline rate used to calculate physician payments taking effect in January. “Physicians will once again begin the year with lower rates as practice costs continue to rise,” the American Academy of Family Physicians said in a statement following release of the rule. The cut is steeper than CMS initially proposed and largely reflects the expiration of a temporary congressional payment boost that expires at the end of 2026, a concern to doctors. CMS Administrator Mehmet Oz said that the rules as a whole ditch the “status quo” of “[rewarding] volume over value, fueling a reactive system of sick care.” Here are some of the provisions that have drawn the most interest: MODIFIER-25 CMS backed off a proposal to cut payments by 50 percent when physicians bill an office visit alongside a minor procedure on the same day. I wrote about this proposal back in August, and noted last month that it prompted a wave of lobbying from certain specialties such as dermatologists. The final rule instead reduces payment for the lower-cost service by 20 percent when doctors bill an office visit alongside certain minor procedures that don’t include a bundled period for follow-up care. The American Academy of Family Physicians says the provision “penalizes family physicians for addressing multiple health needs in one visit and could delay care or push patients to more expensive settings.” The change could affect specialties such as dermatology and podiatry, where doctors often perform procedures and evaluate patients during the same visit. Rahul K. Shah, who leads the American Academy of Otolaryngology–Head and Neck Surgery, tells me that “a smaller cut is still a cut.” “The fundamental problem remains: CMS has not demonstrated that same-day services are duplicative or provided compelling evidence to justify a sweeping, across-the-board 20 percent reduction,” Shah said. “Belief is not evidence.” He said the cut will lead to additional financial pressure on physician practices that are already struggling amid the rising cost of operating and decreasing Medicare physician payments. → Critics of the provision say that Medicare’s payment system already accounts for potential overlap in reimbursements. Within the rule, CMS acknowledged that there is a framework to prevent payment for overlapping work in some cases, but argued that the “approach is piecemeal and both underestimates the amount of overlap” — and fails to capture the full extent of duplicated work when doctors bill for an office visit and certain services at the same time. The final rule “strikes a balance between paying more accurately for services performed on the same day and the real-world impact of this policy,” CMS said. Murad Alam, president of the American Academy of Dermatology Association, said that the entirety of payment cuts in the rule “disproportionately impact services we rely on every day to detect and treat skin cancer at its earliest stages.” REMOTE PATIENT MONITORING CMS is giving physician practices two more years to comply with a proposed requirement that remote patient monitoring be provided by their own employees rather than outside contractors. The policy won’t take effect until January 2029 instead of the beginning of 2027. → I wrote about opposition to this policy change in September, and the Alliance for Connected Care was among those telling regulators that most clinics, health systems, and hospitals rely on outside vendors. “By delaying this requirement, the agency has given patients, practices and health systems time to keep remote-monitoring programs running while we work toward a lasting solution,” said Kyle Zebley, CEO of the American Telehealth Association and executive director of the industry group’s advocacy arm. Zebley and the group’s members had been among those lobbying CMS on the provision, arguing they would be spending the next two years urging the agency to “adopt targeted program-integrity safeguards that address fraud and abuse without cutting off access to proven remote monitoring programs.” “The clock is now running,” he added. → In the rule, the agency also declined to finalize a proposal to replace existing billing codes for remote monitoring with four new Medicare codes, which critics had argued would slash reimbursement and further make it financially unsustainable for providers. However, CMS left the issue on the table for future rulemaking. Caroline Pearson, executive director of the Peterson Center on Healthcare, criticized remote monitoring as a source of recurring Medicare revenue, with providers able to bill what she called “forever codes” without demonstrating that patients still need the service. Pearson called the rule “a check against the rapid growth” of remote patient monitoring, but warned the changes could also prompt some providers to drop the services — which could in turn cut off access for patients who rely on this care. “What comes next has to be smarter: Payment tied to clinical outcomes and targeted to the patients who benefit, so it builds confidence instead of eroding it,” Pearson said. ACOs The new payment rules make a number of positive changes for accountable care organizations (ACOs), which are groups of doctors, hospitals, and other providers that coordinate patient care and share in Medicare savings when they improve quality and lower costs. The rule gives more money for such coordinated care, increasing payments for doctors in certain accountable care programs by 32 percent. The rule also provides ACOs with 75 percent of savings achieved in prior years — up from 50 percent — and lowers costs for patients. Mara McDermott, CEO of advocacy group Accountable for Health, cheered the rule, saying the changes help move Medicare away from paying primarily for the number of services delivered and toward rewarding providers for better health outcomes — and lower costs. McDermott, however, raised concerns similar to other physician groups about the continued “pressure” on physician payments. “Sustaining accountable care requires predictable, adequate resources that reward providers for improving quality and reducing unnecessary spending,” McDermott said. Hospital outpatient payment rules The hospital outpatient payment rule covers how much Medicare pays for things such as same-day surgeries, diagnostic tests, emergency room visits and services provided at hospital-owned clinics. Overall, Medicare payments to hospitals for these services will rise 2.3 percent in 2027, though some hospitals will simultaneously face additional payment cuts tied to the 340B discount drug program. Here are the major flash points within the rule: SITE-NEUTRAL PAYMENTS The Trump administration is expanding its rules around site-neutral payments, which ensure that providers are paid by Medicare at the same rate regardless of where a service is provided. Under the new rules, Medicare will reimburse certain imaging services — such as CT scans and MRIs without contrast — provided at certain hospital outpatient departments similar to what it pays physician offices for these scans. (Sole community hospitals in rural areas would be exempted.) This builds on a policy finalized in last year’s payment rules that imposed site-neural payments on physician-administered drugs — a move strongly opposed by hospitals, which argue that hospital outpatient departments provide care to sicker, more complex patients than doctors’ offices. CMS estimates the new changes will save $260 million in 2027, including $190 million for Medicare and $70 million for beneficiaries, who will pay less out of pocket when they receive care. The agency said that the changes would also begin positively impacting Medicare Advantage savings in 2028. Advocacy groups, such as consumer group Families USA, are among those that have advocated for site-neutral payment policies. Anthony Wright, executive director of Families USA, said the change helps “ensure the same service is the same price regardless of where it is provided.” “For too long, big corporate health systems have bought up doctors’ offices so they can unfairly jack up health care prices with no accountability,” Wright said. Ashley Thompson, a senior official at the American Hospital Association, said the policy is “misguided” and doesn’t take into account the “unique role hospital outpatient departments play in delivering care to patients in communities nationwide.” 340B CMS is changing how Medicare pays hospitals for drugs purchased through the 340B discount drug program. The agency says that it’s cutting reimbursement for these products — provided by drugmakers to hospitals that serve large numbers of low-income patients at a discount — to better reflect hospitals’ acquisition costs. Beginning next year, Medicare will reimburse hospitals for 340B-acquired drugs at 28 percent below their average sales price — the benchmark Medicare uses to set drug payments. That’s a significant drop from the current rate of 6 percent above that benchmark, though less than the 33.4 percent cut CMS initially proposed. Because the changes must be budget-neutral, CMS is using the savings from lower drug payments to boost Medicare reimbursement for other outpatient services by an estimated 7.5 percent. Beth Feldpush, senior vice president of policy and advocacy at America’s Essential Hospitals, called the 340B reimbursement cuts “an existential threat to essential hospitals and the patients they serve.” The move is part of the Trump administration’s efforts to overhaul the 340B discount drug program, which the pharmaceutical industry and some critics on Capitol Hill have argued is being abused by hospitals that don’t need the savings — or aren’t using them to improve patient care. INDUSTRY SPLIT For-profit hospitals benefit because they get higher Medicare payments for outpatient services without absorbing cuts to 340B drug reimbursements since they aren’t eligible to participate in the 340B program. That’s because CMS is lowering payments for 340B drugs and redistributing the savings via higher payments for other outpatient services throughout the entire system. Charlene MacDonald, president and CEO of the Federation of American Hospitals, said the 340B discount drug provisions within the rule are “a win for patients, taxpayers and the hospitals that communities depend on.” “By bringing Medicare drug payments more in line with actual costs, this reform will lower seniors’ out-of-pocket expenses and redirect billions in Medicare dollars where they’re needed most — supporting access to care for patients served by small and rural hospitals across the country,” said MacDonald, whose group represents for-profit hospitals. “Wisconsin reports infant measles death, first in more than three decades,” The Post’s Lena H. Sun reports. “Infant bleeding surged last year as parents refuse vitamin K shot for newborns,” The Post’s Daniel Wu reports. “Trump Administration Delays Awards Slated To Improve Rural America’s Health,” report Sarah Jane Tribble, Arielle Zionts, and Bram Sable-Smith of KFF Health News. This newsletter is published by WP Intelligence, The Washington Post’s subscription service for professionals that provides business, policy and thought leaders with actionable insights. WP Intelligence operates independently from The Washington Post newsroom. |